Iovance Biotherapeutics, Inc. (IOVA) Stock Forecast & Price Prediction 2024, 2025, 2030, 2040, and 2050
Get detailed Iovance Biotherapeutics, Inc. (IOVA) stock forecast for 2024, monthly, along with long-term IOVA price prediction from 2025 to 2050. Look at historical stock performance, analyst recommendations (Buy, Sell, or Hold), and the latest Iovance Biotherapeutics, Inc. headlines.
1 Month Prediction
$20.33 [175.52%]
3 Month Prediction
$28.03 [279.79%]
6 Month Prediction
$22.35 [202.83%]
1 Year Prediction
$28.07 [280.36%]
3 Year Prediction
$43.22 [485.64%]
5 Year Prediction
$58.38 [691.06%]
About Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. is a biotechnology company that specializes in the development and commercialization of immunotherapy products for treating various cancers. Founded in 2007 as Genesis Biopharma, the company underwent a merger in 2013 to become Lion Biotechnologies and rebranded to Iovance Biotherapeutics in 2017. Headquartered in San Carlos, California, Iovance focuses on tumor-infiltrating lymphocyte (TIL) therapies designed to harness the body's immune system to recognize and attack cancer cells.
The company's main product is lifileucel, which is an autologous, ready-to-infuse cell therapy indicated for the treatment of melanoma and metastatic cervical cancer. In February 2024, the U.S. Food and Drug Administration (FDA) granted accelerated approval for lifileucel, which makes it as the first TIL therapy approved for the treatment of unresectable or metastatic melanoma.
Iovance operates a manufacturing facility in Philadelphia and a research facility in Tampa, Florida. As of December 2024, the company employs approximately 557 individuals.
Iovance Biotherapeutics, Inc. (IOVA) Historical Performance
IPO Date
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) went public on 21 December, 2023.
Change
Since inception, IOVA has decreased by 92.83%. In the last 5 years, IOVA has fallen from $21.74 to $7.38, a massive -66.05% decrease since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $46.40 and a low of $3.82.
52 Week Range
$6.7
$18.33
The current price $7.38 is not near the 52-week extremes, which means that the stock is neither overbought nor underbought.
IOVA Stock Price History
Based on IOVA stock's historical price data, this table shows how the stock has performed in the last 5 years. Since 2019, the IOVA stock has fallen from $21.74 - $46.4 to $7.38 - $15.91, which is down -42.73%. Currently, the stock follows downward trend.
Here, we have calculated stock range of IOVA, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $21.74 - $46.4 | $32.71 | 81.19 | 1 Year Change |
| 2021 | $18.57 - $43.84 | $26.83 | 48.62 | 2 Year Change |
| 2022 | $6.39 - $16.65 | $11.33 | -37.24 | 3 Year Change |
| 2023 | $3.82 - $8.74 | $6.55 | -63.72 | 4 Year Change |
| 2024 | $7.38 - $15.91 | $10.34 | -42.73 | 5 Year Change |
IOVA Price Performance
6-Month Performance
IOVA stock dropped by 15.46% in the last six months.
1-Year Performance
The stock has trended downwards by 4.53% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 55.68%.
5-Year Performance
In the last 5 years, the stock has gone down by 66.05%.
According to Iovance Biotherapeutics, Inc.'s historical data, below graph gives us the exact picture of how the IOVA stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 2 years and a decline in 2 years.
2020
67.63% ↑
2021
58.86% ↓
2022
66.53% ↓
2023
27.23% ↑
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Iovance Biotherapeutics, Inc. (IOVA) Financials & Stock Analysis
Total Revenue
Quarterly Revenue: $58.55 M (Q3)
Revenue for Q3 ending 30th September, 2024 increased 88.24% compared to Q2 ending 30th June, 2024.
Annual Revenue: $90.86 M (1Y)
Revenue for trailing 12 months increased 7,541.46% year over year from 31st December, 2023.
Market Capitalization
Iovance Biotherapeutics, Inc. has a market capitalization of $2.25B, which places IOVA in the mid-cap category.
Fundamental Analysis
EPS: $-0.28 (Q3), $-1.89 (1Y)
EPS decreased 17.65% since last quarter, and decreased 24.10% since last year.
Net Income: $-83.54 M (Q3), $-444.04 M (1Y)
Net Income decreased 13.96% since last quarter, and increased 12.16% since last year.
Free Cash Flow: $-61.26 M (Q3), $-384.11 M (1Y)
Free Cash Flow decreased 38.04% since last quarter, and increased 22.65% since last year.
Net Profit Margin: -142.67% (Q3), -488.72% (1Y)
Net Profit Margin decreased 54.30% since last quarter, and decreased 98.53% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for IOVA stock. These indicators help you understand Iovance Biotherapeutics, Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for IOVA stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $8.45 |
| SMA50 | $9.41 |
| SMA200 | $10.25 |
| RSI | 23.17 |
| Beta | 0.59 |
SMA20 > Current Price
This signals IOVA stock is in short-term bearish momentum.
SMA50 > Current Price
This signals IOVA stock is in mid-term bearish momentum.
SMA200 > Current Price
This signals IOVA stock is in long-term bearish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for IOVA stock is Bearish. Out of all indicators, 3 indicates bullish signals, 5 signals bearish trends and 1 gives neutral trends. The IOVA stock forecast was last updated on 22 December, 2024.
Iovance Biotherapeutics, Inc. (IOVA) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $28.07 by the end of 2025, and can reach around $48.98 to $28.26 in 2026. And, the long-term forecast suggests that the stock may further jump to $49.10 - $61.87 in 2028, and $42.79 - $99.07 by 2031. So, the IOVA stock shows a strong upward trend in the next several years.
Short-term IOVA Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-01 | $20.33 | 175.47% |
| 2025-02 | $28.74 | 289.43% |
| 2025-03 | $28.03 | 279.81% |
| 2025-04 | $25.42 | 244.44% |
| 2025-05 | $22.84 | 209.49% |
| 2025-06 | $22.35 | 202.85% |
| 2025-07 | $25.79 | 249.46% |
| 2025-08 | $24.76 | 235.5% |
| 2025-09 | $23.32 | 215.99% |
| 2025-10 | $22.84 | 209.49% |
| 2025-11 | $25.56 | 246.34% |
| 2025-12 | $28.07 | 280.35% |
In 2025, the IOVA stock price is expected to fluctuate between $20.33 and $28.74. According to the monthly forecast, the stock could rise to $28.07 by December 2024. If compared to the IOVA's current price, the stock could gain 280.35% by the end of this year.
Long-term IOVA Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $48.98 | $42.74 | $28.26 | 282.93% |
| 2027 | $43.41 | $47.27 | $75.54 | 923.58% |
| 2028 | $49.10 | $59.49 | $61.87 | 738.35% |
| 2029 | $42.85 | $59.69 | $93.45 | 1166.26% |
| 2030 | $72.74 | $74.56 | $95.45 | 1193.36% |
| 2031 | $42.79 | $26.10 | $99.07 | 1242.41% |
| 2032 | $76.44 | $56.53 | $70.20 | 851.22% |
| 2033 | $88.55 | $130.61 | $122.27 | 1556.78% |
| 2034 | $44.34 | $170.50 | $93.83 | 1171.41% |
| 2035 | $26.32 | $84.92 | $106.43 | 1342.14% |
| 2036 | $119.05 | $155.08 | $156.71 | 2023.44% |
| 2037 | $125.17 | $149.96 | $68.23 | 824.53% |
| 2038 | $136.66 | $65.19 | $126.86 | 1618.97% |
| 2039 | $139.23 | $116.10 | $131.39 | 1680.35% |
| 2040 | $100.43 | $126.17 | $200.84 | 2621.41% |
| 2041 | $147.81 | $190.91 | $125.14 | 1595.66% |
| 2042 | $153.64 | $119.29 | $152.84 | 1971.0% |
| 2043 | $232.68 | $157.83 | $71.22 | 865.04% |
| 2044 | $154.48 | $193.92 | $158.86 | 2052.57% |
| 2045 | $149.67 | $216.33 | $180.42 | 2344.72% |
| 2046 | $160.99 | $175.02 | $228.72 | 2999.19% |
| 2047 | $159.43 | $114.00 | $175.03 | 2271.68% |
| 2048 | $185.22 | $132.07 | $179.88 | 2337.4% |
| 2049 | $238.93 | $299.12 | $95.18 | 1189.7% |
| 2050 | $184.66 | $98.97 | $270.66 | 3567.48% |
Iovance Biotherapeutics, Inc. (IOVA) Stock Price Prediction & Forecast 2024 - 2025
At the start of 2024, the IOVA stock was at $7.73. Today, it is trading at $7.38, which is -4.53% decrease from price at the beginning of the year.
In early 2025, the IOVA price is expected to climb to $33.65, a change of 355.90% from the current price. By mid-2025, the stock may move down by -52.63% on $15.94 and end the year at $37.10, which is 402.65% compared to today's price.
Iovance Biotherapeutics, Inc. (IOVA) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant appreciation in the IOVA stock. During this period, the IOVA's price is forecasted to shift from $48.98 to $95.45, which is 94.88% gain.
In 2026, the stock would possibly open at $48.98, descends to $42.74 by mid-year, and wraps up at $28.26, reflecting a 282.98% increase from today's price. Further moving to 2030, the stock can kick off the year at $72.74, drop to $74.56 by mid-year, and finish at $95.45, which is 1193.41% change from current price.
Iovance Biotherapeutics, Inc. (IOVA) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $42.79 to $200.84, which is up 1242.48%
In 2031, we can expect IOVA to fluctuate between $42.79 and $99.07, a shift indicating a 1242.48% gain by year-end compared to current price. And Until 2040, IOVA can likely vary from $100.43 to $200.84. By the end of 2040, the stock could record a 2621.46% rise from today's stock price.
Iovance Biotherapeutics, Inc. (IOVA) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the IOVA stock can see an an upturn from $147.81 to $270.66 in this period. In 2041, the stock can experience a high of $190.91 by mid-year, closing the year at $125.14. This results in a 2486.81% increase from today.
Moving towards the end of 2050, IOVA is projected to open the year at $184.66. The stock may dip to $98.97 during mid-year and finish the year at $270.66. Compared to the stock's current price, this translates to an overall gain of 3567.42% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
IOVA : Buy, Sell Or Hold?
Analyst Ratings
Based on 13 analysts, 3 rated as a strong buy, 8 recommended a buy, 2 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.So, according to analyst ratings, the recommendation for IOVA stock is Buy.
Expert Analysis
According to IOVA short-term and long-term forecast, Iovance Biotherapeutics, Inc. shares are projected to go up by 3567.48%, and reach a value of $270.66 per share by 2050.
As per technical analysis, indicators show a Bearish sentiment, while Fear & Greed Index stands at 42.857142857142854, which signals Fear. Also, IOVA has recorded 8/30 green days, which reflects a 36.36363636363637% positivity rate with a price volatility of 0.05%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that IOVA stock is undervalued. So, Based on IOVA prediction and analysis, it may be the best time to sell IOVA stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "IOVA” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.